Crosignani A - Search Results

1

Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.

Invernizzi P, Setchell KD, Crosignani A, Battezzati PM, Larghi A, O'Connell NC, Podda M. Invernizzi P, et al. Among authors: crosignani a. Hepatology. 1999 Feb;29(2):320-7. doi: 10.1002/hep.510290220. Hepatology. 1999. PMID: 9918905 Clinical Trial.

2

Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis.

Invernizzi P, Battezzati PM, Crosignani A, Perego F, Poli F, Morabito A, De Arias AE, Scalamogna M, Zuin M, Podda M. Invernizzi P, et al. Among authors: crosignani a. J Hepatol. 2003 Apr;38(4):401-6. doi: 10.1016/s0168-8278(02)00440-3. J Hepatol. 2003. PMID: 12663229

3

T-cell receptor polymorphism in primary biliary cirrhosis.

Selmi C, Invernizzi P, Tripputi P, Battezzati PM, Bignotto M, Zuin M, Crosignani A, Podda M. Selmi C, et al. Among authors: crosignani a. Ann Ital Med Int. 2003 Jul-Sep;18(3):149-53. Ann Ital Med Int. 2003. PMID: 14621425

4

Clinical features and management of primary biliary cirrhosis.

Crosignani A, Battezzati PM, Invernizzi P, Selmi C, Prina E, Podda M. Crosignani A, et al. World J Gastroenterol. 2008 Jun 7;14(21):3313-27. doi: 10.3748/wjg.14.3313. World J Gastroenterol. 2008. PMID: 18528929 Free PMC article. Review.

5

Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls.

Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, Almasio P, Rosina F, Marzioni M, Fabris L, Muratori L, Qi L, Seldin MF, Gershwin ME, Podda M; Italian PBC Genetic Study Group. Invernizzi P, et al. Hepatology. 2008 Dec;48(6):1906-12. doi: 10.1002/hep.22567. Hepatology. 2008. PMID: 19003916 Free PMC article.

6

Hepatitis C virus testing in primary biliary cirrhosis.

Bertolini E, Battezzati PM, Zermiani P, Bruno S, Moroni GA, Marelli F, Villa E, Manenti F, Zuin M, Crosignani A, et al. Bertolini E, et al. Among authors: crosignani a. J Hepatol. 1992 May;15(1-2):207-10. doi: 10.1016/0168-8278(92)90037-p. J Hepatol. 1992. PMID: 1324271

7

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, Setchell KD. Colombo C, et al. Among authors: crosignani a. Hepatology. 1992 Oct;16(4):924-30. doi: 10.1002/hep.1840160412. Hepatology. 1992. PMID: 1398498 Clinical Trial.

8

Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.

Crosignani A, Battezzati PM, Setchell KD, Camisasca M, Bertolini E, Roda A, Zuin M, Podda M. Crosignani A, et al. Hepatology. 1991 Feb;13(2):339-44. Hepatology. 1991. PMID: 1671665 Clinical Trial.

9

Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.

Zuin M, Petroni ML, Grandinetti G, Crosignani A, Bertolini E, Battezzati PM, Podda M. Zuin M, et al. Among authors: crosignani a. Scand J Gastroenterol. 1991 Mar;26(3):257-62. doi: 10.3109/00365529109025039. Scand J Gastroenterol. 1991. PMID: 1853147 Clinical Trial.

10

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.

Crosignani A, Podda M, Battezzati PM, Bertolini E, Zuin M, Watson D, Setchell KD. Crosignani A, et al. Hepatology. 1991 Dec;14(6):1000-7. Hepatology. 1991. PMID: 1959845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters